Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

CMMBCMMB
3 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in CHEMOMAB THERAPEUTICS LTD

No. Jane Street Group exited its CMMB (Chemomab Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 15,598 shares worth $25,737. Jane Street Group first reported CMMB in Q3 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$56,574

Total Shares Change

-21,511

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.79
0
2025-Q4
Decreased
15,598
-27.5%
$25,7370.0%$1.64
0
2025-Q3
New
21,511
-
$56,5740.0%$2.65
32

Other major holders of CMMB: MORGAN STANLEY, CITADEL ADVISORS LLC, RHUMBLINE ADVISERS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used